A Study to Evaluate Safety and Effectiveness in Patients of All Age Groups Excluding Less Than 12 Months Old Infants With Diabetes Mellitus in Routine Clinical Practice in Korea

NCT02779413 · clinicaltrials.gov ↗

COMPLETED

Status

3303

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes

Interventions

DRUG: insulin degludec

Sponsor

Novo Nordisk A/S